Product Datasheet

 
Product Description
 
Product: Kallikrein, Human Plasma
Catalog Number: HPKA
Product Page: https://www.mol-innov.com/products/IHUKLK1MG
Description: Activation of Prekallikrein with Factor alpha-XIIa produces the enzymatically active Kallikrein. Kallikrein is a serine protease which consists of a heavy chain (Mr 52kD) and light chains (Mr either 36 or 33 kD) linked by disulfide bridges. Kallikrein possesses enzymatic activity toward Factor XII, HK, Plasminogen, Factors XI, IX, and VII, prorenin and the complement system. After activation, the activating enzyme Factor XIIa is removed by affinity chromatography. Human Kallikrein purity is >95percent by SDS-PAGE and shows complete reduction upon incubation with 2-mercaptoethanol. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I & II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease).
Recommended Storage: SAMPLE
Minimum Shelf Life: 484.50
Source: 2.0 mg/ml
Molecular Weight: Proteins
Extinction Coefficient: 86,000 - 88,000
Antigen: -70 C
Target: Frozen liquid
Target Molecular Weight: KALLIKREIN/PREKALLIKREIN
Host: 2270.5
Clonality: 5
Isotype: Human plasma
Clone: s
Applications: Dry ice
Cross-reactivity: 3 years from delivery
 
Sample Characteristics
 
Lot Number: HPKA-IHUKLK5MG
Aliquot: 1 x Human Kallikrein Purified 5mg
Concentration: 510
Volume: 2390
Titer: 0.004M Sodium Acetate; 0.15M NaCl; pH 5.3
Buffer: SAMPLE
Form: 1.0 mg
Preservative: 0.5 ml
 
Optimal experimental conditions and working dilutions must be determined by the end user. Sample concentration and volume are for example purposes only and do not necessarily represent the product that will be received. Please contact us for a current lot-specific product datasheet.
 
For in vitro laboratory use only
 
Molecular Innovations, Inc. - 46430 Peary Court, Novi, MI 48377, USA
Tel: (888) 557-5055 - Fax: (248) 896-0148 - info@mol-innov.com